Advertisement
Advertisement
SKIN
The Beauty Health Company Class A Common Stock
1.00
USDSponsored
-0.10
-8.73%
Mar 25, 16:00 UTC -4
Closed
Pre-Market
0.97
-0.03
-2.50%
SKIN Earnings Reports
Positive Surprise Ratio
SKIN beat 14 of 20 last estimates.
70%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$67.94M
/-$0.07
Implied change from Q4 25 (Revenue/ EPS)
-17.55%
/+16.67%
Implied change from Q1 25 (Revenue/ EPS)
-2.38%
/-12.50%
The Beauty Health Company Class A Common Stock earnings per share and revenue
On Mar 12, 2026, SKIN reported earnings of -0.06 USD per share (EPS) for Q4 25, missing the estimate of -0.05 USD, resulting in a -14.29% surprise. Revenue reached 82.40 million, compared to an expected 79.36 million, with a 3.83% difference. The market reacted with a +19.81% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 7 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 67.94 million USD, implying an increase of 16.67% EPS, and decrease of -17.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were The Beauty Health Company Class A Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, The Beauty Health Company Class A Common Stock reported EPS of -$0.06, missing estimates by -14.29%, and revenue of $82.40M, 3.83% above expectations.
How did the market react to The Beauty Health Company Class A Common Stock's Q4 2025 earnings?
The stock price moved up 19.81%, changed from $1.06 before the earnings release to $1.27 the day after.
When is The Beauty Health Company Class A Common Stock expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for The Beauty Health Company Class A Common Stock's next earnings report?
Based on 7
analysts, The Beauty Health Company Class A Common Stock is expected to report EPS of -$0.07 and revenue of $67.94M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement